Dry Eye Disease

Showing NaN - NaN of 8

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Dry Eye Disease Trial in United States (0.02% Betamethasone Sodium Phosphate, 0.04% Betamethasone Sodium Phosphate, Placebo)

Completed
  • Dry Eye Disease
  • 0.02% Betamethasone Sodium Phosphate
  • +2 more
  • Dothan, Alabama
  • +27 more
Nov 9, 2022

Dry Eye Disease, Sjögren Syndrome Trial in United States (Tivanisiran sodium ophthalmic solution, Vehicle ophthalmic solution)

Recruiting
  • Dry Eye Disease
  • Sjögren Syndrome
  • Tivanisiran sodium ophthalmic solution
  • Vehicle ophthalmic solution
  • Birmingham, Alabama
  • +38 more
Sep 15, 2022

Dry Eye Disease, Kerato Conjunctivitis Sicca Trial in United States (Pilocarpine Ophthalmic Topical Cream, Dose 1, Pilocarpine

Completed
  • Dry Eye Disease
  • Kerato Conjunctivitis Sicca
  • Pilocarpine Ophthalmic Topical Cream, Dose 1
  • +3 more
  • Chandler, Arizona
  • +18 more
Aug 26, 2022

Dry Eye Disease Trial in United States (SURF-100 (Combination of 0.3% Mycophenolic Acid and 0.01% Betamethasone Sodium

Completed
  • Dry Eye Disease
  • SURF-100 (Combination of 0.3% Mycophenolic Acid and 0.01% Betamethasone Sodium Phosphate)
  • +6 more
  • Phoenix, Arizona
  • +39 more
Apr 10, 2022

Dry Eye Disease Trial in United States (Lifitegrast, Placebo)

Completed
  • Dry Eye Disease
  • Artesia, California
  • +30 more
Jun 2, 2021

Dry Eye Disease Trial in United States (Lifitegrast, Placebo)

Completed
  • Dry Eye Disease
  • Birmingham, Alabama
  • +40 more
Jun 2, 2021

Dry Eye Disease Trial in United States (Lifitegrast, Placebo)

Completed
  • Dry Eye Disease
  • Artesia, California
  • +22 more
Jun 2, 2021

Dry Eye Disease Trial in United States (P-321 Ophthalmic Solution, P-321 Ophthalmic Solution )

Terminated
  • Dry Eye Disease
  • P-321 Ophthalmic Solution
  • P-321 Ophthalmic Solution placebo
  • Artesia, California
  • +6 more
Sep 12, 2018